FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/103600 [Registered on: 11/02/2026] Trial Registered Prospectively
Last Modified On: 25/08/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Biological
Ayurveda
Other (Specify) [Jalaukavacharana]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A Study to Evaluate Leech Therapy and Thrombophob Gel in Treating Thrombophlebitis (Inflammation of Veins with Blood Clots)” 
Scientific Title of Study   Randomized controlled clinical study to evaluate the efficacy of jalaukavacharana (leech therapy) in thrombophlebitis (vranshotha) with thrombophob gel. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr NILESH ASHOK NANDALE 
Designation  PG Scholar 
Affiliation  Siddhakala Ayurveda Hospital , Sangamner 
Address  OPD number 6 Shalyatantra department,Siddhakala ayurved mahavidyalay Sangamner ,Pimparne road ,Sangamner khurd,sangamner 422605 Ahemadnagar MAHARASHTRA
OPD number 6 , Shalyatantra department,Siddhakala ayurved mahavidyalay Sangamner ,Pimparne road ,Sangamner khurd,sangamner 422605 Ahemadnagar,Maharashtra
Ahmadnagar
MAHARASHTRA
422605
India 
Phone  7745088395  
Fax    
Email  nileshnandale09@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Naimish Kishor Saraf 
Designation  Head Of Department Of Shalyatantra 
Affiliation  Siddhakala Ayurveda Hospital , Sangamner 
Address  OPD number 6 Shalyatantra department,Siddhakala ayurved mahavidyalay Sangamner ,Pimparne road ,Sangamner khurd,sangamner 422605 Ahemadnagar MAHARASHTRA
OPD number 6, Shalyatantra department, Siddhakala ayurved mahavidyalay Sangamner , Pimparne road , Sangamner khurd,sangamner 422605 Ahemadnagar MAHARASHTRA
Ahmadnagar
MAHARASHTRA
422605
India 
Phone  9766786123  
Fax    
Email  naimishsaraf@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr NILESH ASHOK NANDALE 
Designation  PG Scholar 
Affiliation  Siddhakala Ayurveda Hospital , Sangamner 
Address  OPD number 6 Shalyatantra department,Siddhakala ayurved mahavidyalay Sangamner ,Pimparne road ,Sangamner khurd,sangamner 422605 Ahemadnagar MAHARASHTRA
OPD number 6, Shalyatantra department,Siddhakala ayurved mahavidyalay Sangamner , Pimparne road , Sangamner khurd,sangamner 422605 Ahemadnagar MAHARASHTRA
Ahmadnagar
MAHARASHTRA
422605
India 
Phone  7745088395  
Fax    
Email  nileshnandale09@gmail.com  
 
Source of Monetary or Material Support  
Siddhakala Ayurveda Mahavidyalaya , Sangamner Khurd, Pimparne Road, Sangamner 
 
Primary Sponsor  
Name  Dr NILESH ASHOK NANDALE 
Address  OPD number 6 Shalyatantra department,Siddhakala ayurved mahavidyalay Sangamner ,Pimparne road ,Sangamner khurd,sangamner 422605 Ahemadnagar MAHARASHTRA 
Type of Sponsor  Other [(SELF)] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nilesh Ashok Nandale  Siddhakala Ayurved mahavidyalaya and hospital,Pimparne road , sangamner   OPD Number 6, Shalyatantra department, siddhakala Ayurved mahavidyalaya, pimparne road,sangamner
Ahmadnagar
MAHARASHTRA 
7745088395

nileshnandale09@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Board of Research and statistics committee of siddhakala Ayurved mahavidyalaya sangamner   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:I809||Phlebitis and thrombophlebitis ofunspecified site. Ayurveda Condition: VRANASOPAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-jalaukAvacaraNam, जलौकावचरणम् (Procedure Reference: Kaviraj AmbikaDatt Shastri , Sushrut Samhita Purvardh, Sutrasthan 13/5, Chaukhamba publication ; 2017, Procedure details: leech application done only 1 time & observation made 2nd 4th & 6th day.)
2Comparator Arm (Non Ayurveda)-Thrombophoeb gel.local application BD for 7 days
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. Subjects of age between 18-70 years.
2. Irrespective of Gender
3. Aagantuj Vranashotha with special focus on Acute Superficial thrombophlebitis.
4. Patients have developed thrombophlebitis due to IV Infusion and medication, trauma and infection of veins.
5. Thromboplebitis involving area less than 5 cm. 
 
ExclusionCriteria 
Details  1.Patients receiving cancer chemotherapy drugs, steroid.
2.patients with known case of coagulopathies, polycythemia vera, buergers disease, mondors disease, DVT ,DM and arteriovenous disorders.
3.Patients with known case of HIV, immunosuppressive disorder,haemophilia, hepatitis B and other blood transmitting infection.
4.lactating mother ,pregnant mother. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To compare the clinical efficacy of Jalaukavcharan (leech therapy) and Thrombophob gel in the management of thrombophlebitis. such as reduction in pain, redness, swelling and palpable venous cord.  0th Day (Baseline Assessesment) , 2nd day (Follow up), 4th Day(Follow Up ), 6th Day (Final Assessesment) 
 
Secondary Outcome  
Outcome  TimePoints 
1.To assess the reduction in pain, swelling, and local tenderness in patients receiving Jalaukavcharan versus Thrombophob gel.
2.To evaluate the time taken for visible clinical improvement (such as reduction in limb circumference or erythema)
3.To assess any adverse effects or complications associated with Jalaukavcharan and Thrombophob gel.
4.To correlate the Ayurvedic signs and symptoms of Vranshotha with the clinical presentation of thrombophlebitis.
5.To study the changes happening in Jalauka (use for jalaukavacharan) over the time 
2nd Day (Baseline Assessesment) , 4th Day (Follow Up ), 6th Day (Final Assessesment) 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   04/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This Study is Randomized Open Labelled Controlled Clinical Trial Comparing The Safety And Efficacy Of Jaluakavcharana For One Time And Controlled Local Application Of Thrombophoeb Gel For 7 Days BD In 60 Patients Divided in Two Groups And Observed The Visual Infusion Phlebitis Score And VAS Scale. 
Close